Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Health Care Reform Begs Key Questions

This article was originally published in PharmAsia News

Executive Summary

Analysts believe that China's RMB 850 billion injection into its health care reform will have a positive effect during the current financial crisis. However, Beijing University's director in the China medicine economics research center points out that three questions remain that need to be addressed. The first is the lack of regulatory details on the spending areas. The second is the omission of the avenues of disbursement. The previous program used a top-down distribution model that did not achieve the desired results, thus there needs to be a market approach that reimburses the public directly. Third is the lack of clarification on how to solve the issue of medical services not meeting demand. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069906

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel